Many US COVID-19 Guidances Set To Sunset With Emergency Declaration
Executive Summary
But some, including some related to inspections and master protocols, will remain in effect to allow for revisions or a transition out of the pandemic posture.
You may also be interested in...
US FDA Removes Minimum Efficacy Bar For COVID-19 Vaccines
Instead of the 50% threshold, the FDA in updated guidance says that efficacy confidence intervals and point estimates should be ‘appropriately justified.’
US FDA Program Streamlining COVID-19 Treatment Development Still Working As Emergency Ends
Any program changes would not occur until after a thorough assessment, the agency said.
US FDA ‘Brainstorms’ For Ways To Resume Pre-Pandemic Inspection Cadence
The FDA's drug inspections director discusses trends and challenges in remarks at a Georgia GMP conference, while declining to share specific ideas generated in last week’s agency brainstorming session.